Targeted Intermittent Treatment in Chronic Schizophrenia
نویسندگان
چکیده
منابع مشابه
Targeted Intermittent Treatment in Chronic Schizophrenia
remission, symptom recurrence, or relapse, despite continuous antipsychotic treatment. This also applies to depot neuroleptic treatment, which minimizes adherence problems. Several studies suggest that with careful clinical observation, substantial reduction of maintenance doses can, for many patients, lead to improvement in some areas of subjective and objective well-being and to a diminution ...
متن کاملRisks of intermittent antipsychotic treatment in schizophrenia.
To the Editor: We read with great interest an important contribution by Gaebel et al1 in which they compared antipsychotic maintenance treatment with discontinuation and intermittent treatment in first-episode schizophrenia. We note several caveats in interpreting their crucial findings for well-balanced decision-making. The authors found that about half of patients in the intermittent treatmen...
متن کاملTargeted treatment for chronic lymphocytic leukemia
The treatment of chronic lymphocytic leukemia (CLL) has evolved over the last few decades. Recognition has increased of several key components of CLL biology currently manipulated for therapeutics. A milestone in the treatment of CLL was reached with the incorporation of immunotherapy with conventional chemotherapy. The fludarabine/cyclophosphamide/rituximab combination has demonstrated surviva...
متن کاملIntermittent drug techniques for schizophrenia.
Intermittent drug techniques refer to the "use of medication only during periods of incipient relapse or symptom exacerbation rather than continuously." The aim is to reduce the risk of adverse effects of antipsychotics by "reducing long-term medication exposure for patients who are receiving maintenance treatment while limiting risk of relapse," with a further goal of improving social function...
متن کاملHerbal Medicine in the Treatment of Schizophrenia: A Review
As a chronic psychiatric disorder, schizophrenia affects the worldwide population with a lifetime prevalence of 1% and considerable long-term mortality, morbidity, and burden. Besides the adverse effects of routine treatment regimens, a significant portion of patients remain symptomatic despite treatment, especially those with negative symptoms which are the major disabling factors in these pat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Psychiatry
سال: 2013
ISSN: 1664-0640
DOI: 10.3389/fpsyt.2013.00013